GHK-Cu Peptide Therapy Skin Rejuvenation & Anti-Aging What is GHK-Cu Peptide Therapy
The maintenance dose is generally 1500mcg once a month, or at a schedule determined by the physician based on the patient's ongoing clinical needs and blood test results
Products are not intended for human or veterinary use, consumption, injection, or administration of any kind
Body composition changes (fat loss, improved recovery) become noticeable at weeks 4 to 8
The most common causes include: Inadequate dietary intake (common in vegetarians/vegans) Malabsorption syndromes (e.g., celiac or Crohns disease) Atrophic gastritis Long-term use of acid-reducing medications Pernicious anemia (an autoimmune condition) B12 deficiency is one of the leading reversible causes of anemia
A peptide also cannot overcome ongoing overtraining, poor nutrition, uncontrolled blood sugar, untreated thyroid dysfunction, low testosterone when clinically relevant, vitamin or mineral deficiencies, or inadequate rest
